Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Volume 2
Year 2015
URL http://goo.gl/QDSB5B
#Kidney
KONNECTI ON
Editor: Tejas Desai | Chief: Cynthia Christiano | Free subscription by emailing myFellowship@ecu.edu
Cynthia Christiano
Malvinder Parmar
Paras Dedhia
Siva Sridharan
Ahmed Elebiary
Denise Thomson
Francesco Iannuzzella
Xavier Vela
Pankaj Jawa
Tejas Desai
LIT IN A MINUTE
THE HARMONIZE TRIAL
PMID: 25402495
For decades kidney docs have relied upon resin therapy to manage hyperkalemia in
advanced & end-stage kidney disease patients. The most common resin used,
kayexalate, surprisingly has little evidence to support its effectiveness. Most of its
(continued next page)
benefits are anecdotally reported, as are the real and horrific
SELFIES
BACK TO
SCHOOL...ONLINE
DEPOSITS
SPECIAL FEATURE
Rodney Dangerfield in Back to School (1986)
An electron micrograph of a
sub-epithelial dense deposit. A
podocyte is seen in the bottom left
quadrant. Adjacent to the dense
deposit are evenly-spaced
protrusions -- the foot processes (red
arrows). The thick gray stripe is the
glomerular basement membrane,
which is uniform in color
(suggesting an absence of
intramembranous deposits). There
is speculation regarding the
components of the dense deposit,
but no single component has been
consistently identified.
LIT IN A MINUTE
THE HARMONIZE TRIAL
side effect of colonic necrosis. Thankfully,
there's a promising drug that can manage
hyperkalemia without the intestinal side
effects...ZS-9. We first came to learn about
ZS-9 in 2013. As an experimental
compound, ZS-9 had a nine-times greater
affinity for intestinal potassium than
kayexalate (hence the #9 in the name). In
late 2014, we learned of its name (sodium
zirconium cyclosilicate) and that it could
PMID: 25402495